RFL (Rafael Holdings) Short Ratio


RFL Rafael Holdings Inc RFL
51 GF Score
Price $2.23
GF Value $1.36
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Rafael Holdings Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RFL
51GF Score
Rafael Holdings Inc RFL
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rafael Holdings (RFL) Overvalued in 2026?

Based on GuruFocus' analysis, Rafael Holdings stock appears to be overvalued. The current stock price of $2.23 is trading 64% above its estimated GF Value™ of $1.36. GuruFocus considers Rafael Holdings to be Significantly Overvalued.

Key valuation signals for RFL:

  • Short Ratio:
  • GF Value™: $1.36 vs. price of $2.23 (64% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the RFL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rafael Holdings Business Description

Address 520 Broad Street, Newark, NJ, USA, 07102
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
51GF Score

Get the complete analysis for RFL

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.23
Price
$1.36
GF Value